Merck on Monday announced the groundbreaking of its new Virginia pharmaceutical manufacturing facility, a cornerstone of the company’s $70 billion U.S. investment strategy. The 400,000-square-foot site in Elkton, Virginia, is expected to create 500 full-time positions once operational and generate roughly 8,000 construction jobs during development.As one of the largest pharmaceutical investments of President Donald Trump’s second term, Merck’s push comes as the administration is prioritizing making pharmace ...